CS
GMAB icon

Candriam SCA’s Genmab GMAB Stock Holding History

Candriam SCA’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-106,291
Closed -$3.69M – 787
2023
Q1 		$3.69M Sell
106,291
-1,847
-2% -$71K 0.03% 436
2022
Q4 		$4.58M Sell
108,138
-14,373
-12% -$592K 0.03% 401
2022
Q3 		$3.94M Buy
122,511
+2,087
+2% +$73.3K 0.03% 433
2022
Q2 		$3.91M Sell
120,424
-36,978
-23% -$1.2M 0.03% 364
2022
Q1 		$5.69M Buy
157,402
+18,914
+14% +$649K 0.04% 325
2021
Q4 		$5.48M Buy
138,488
+2,040
+1% +$85.1K 0.04% 348
2021
Q3 		$5.96M Buy
136,448
+136,312
+100,229% +$6.12M 0.04% 364
2021
Q2 		$6K Sell
136
-76,313
-100% -$2.94M ﹤0.01% 854
2021
Q1 		$2.98M Buy
76,449
+67
+0.1% +$2.52K 0.02% 456
2020
Q4 		$3.11M Sell
76,382
-77,181
-50% -$2.89M 0.02% 467
2020
Q3 		$5.62M Buy
153,563
+7,133
+5% +$258K 0.05% 333
2020
Q2 		$4.96M Sell
146,430
-46,432
-24% -$1.27M 0.05% 334
2020
Q1 		$4.21M Buy
192,862
+240
+0.1% +$5.35K 0.05% 395
2019
Q4 		$4.3M Buy
+192,622
New +$4.2M 0.05% 407

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Candriam SCA's GMAB Position: Q2 2023 in Review

Candriam SCA sold out of Genmab (GMAB) in Q2 2023, closing a stake of 106,291 shares — an estimated $3.69M sold.

Candriam SCA first reported a position in GMAB in Q4 2019 and held it in 14 quarters. The position peaked at $5.96M in Q3 2021. 213 funds tracked by Wall St. Rank hold GMAB as of Q2 2023.

  • Candriam SCA reported no remaining Genmab position as of Q2 2023 after selling out during the quarter.
  • Candriam SCA sold 106,291 Genmab shares in Q2 2023, an estimated $3.69M.
  • Candriam SCA first reported a position in Genmab in Q4 2019 and held it in 14 quarters.
  • Candriam SCA's Genmab position peaked at $5.96M in Q3 2021.
  • 213 funds tracked by Wall St. Rank held Genmab as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.